Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-17

Clinical Trial Update: Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.

View source ↗

Summary

This completed clinical trial evaluated a combination of Rhodiola rosea extract and saffron extract for managing mild to moderate depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rhodiola extract (Rhodiola rosea extract)
  • Saffron extract (Crocus sativus extract)

Snippet

Sponsor: PiLeJe | Conditions: Mild to Moderate Depression | Status: COMPLETED